Возраст домена | n/a |
Дата окончания | n/a |
PR | 5 |
ИКС | n/a |
Страниц в Google | 45300 |
Страниц в Яндексе | 28 |
Dmoz | Нет |
Яндекс Каталог | Нет |
Alexa Traffic Rank | 6879319 |
Alexa Country | Нет данных |
История изменения показателей | Авторизация |
Идет сбор информации... Обновить
WiCON | Pharma China (Web Edition)
n/a
n/a
GB2312
85.58 КБ
784
5 928 симв.
4 936 симв.
Данные предоставлены сервисом semrush
Сайт | Общие фразы | PR | тИЦ | Alexa Rank | Alexa Country | |
---|---|---|---|---|---|---|
businessweek.com | 13 | 8 |
0 | 516471 | 175594 | |
reuters.com | 10 | 8 |
0 | 654 | 314 | |
wikipedia.org | 9 | 9 |
0 | 5 | 6 | |
linkedin.com | 8 | 9 |
0 | 25 | 10 | |
appliedbiosystems.com | 8 | 3 |
0 | 413811 | 348878 | |
forbes.com | 7 | 8 |
0 | 289 | 109 | |
wsj.com | 7 | 8 |
0 | 614 | 165 | |
google.com | 7 | 9 |
0 | 1 | 1 | |
deloitte.com | 6 | 7 |
0 | 3854 | 2294 | |
glassdoor.com | 6 | 7 |
0 | 408 | 96 | |
kintera.org | 1 | 6 |
20 | 127697 | 31251 | |
gradireland.com | 1 | 7 |
0 | 98317 | 846 | |
foreignercn.com | 1 | 5 |
10 | 248812 | 24684 | |
finviz.com | 1 | 5 |
0 | 4231 | 1422 | |
facebook.com | 1 | 9 |
0 | 3 | 3 | |
diadiem.com | 1 | 6 |
0 | 467562 | 5779 | |
china.org.cn | 1 | 7 |
0 | 21521 | 7318 | |
chinadaily.com.cn | 1 | 8 |
0 | 499 | 80 | |
britishchamber.cn | 1 | 5 |
10 | 1059717 | 1116193 | |
Еще 31 сайт после авторизации |
Данные предоставлены сервисом semrush
Ссылок в Alexa | 57 |
Данные linkpad ( 21 Июня 2014 ) | |
Количество ссылок на сайт | 266 |
Количество доменов, которые ссылаются на сайт | 48 |
Количество найденных анкоров | 9 |
Исходящие (внешние) ссылки домена | 74 |
Количество доменов, на которые ссылается сайт | 21 |
Количество исходящих анкоров | 18 |
Внешние ссылки главной страницы ( 1 ) | |
heightow.com | www.heightow.com |
Внутренние ссылки главной страницы ( 110 ) | |
/ | Home |
WebEdition/index.asp | Pharma China Web Edition |
Archives/index.asp | Pharma China Archives |
Databases/index.asp | Online Databases |
Download/index.asp | Subscription/Order/Info |
Services/index.asp | <img> |
Databases/snapiindex.asp | China Pharma Providers |
AboutUs/index.asp | <img> |
WebEdition/index_news.asp | <img> |
webedition/index_news.asp?sortid=14 | <img> |
webedition/index_news.asp?sortid=11 | <img> |
webedition/index_news.asp?sortid=13 | <img> |
webedition/index_news.asp?sortid=15 | <img> |
webedition/index_news.asp?sortid=23 | Legal/IPR News |
webedition/index_news.asp?sortid=12 | <img> |
webedition/index_news.asp?sortid=17 | <img> |
webedition/index_news.asp?sortid=10 | <img> |
webedition/index_news.asp?sortid=16 | <img> |
webedition/index_news.asp?sortid=27 | <img> |
WebEdition/index_1.asp | <img> |
webedition/index_1.asp?sortid=25 | Editorials |
webedition/index_1.asp?sortid=27 | Commentaries |
webedition/index_1.asp?sortid=28 | Expert Opinions |
webedition/index_1.asp?sortid=29 | Interviews |
webedition/index_1.asp?sortid=35 | Case Studies |
webedition/index_1.asp?sortid=30 | Company Profiles |
webedition/index_1.asp?sortid=34 | Editor´s Picks |
myself/weekly_email.asp | <img> |
myself/weekly_email_basic.asp | <img> |
information/index.asp | <img> |
terms/terms.asp | <img> |
terms/privacy.asp | <img> |
Download/index_2.asp | <img> |
WebEdition/index_1_news.asp?id=6587&sortid=34 | Chief Editor James Shen offers his monthly review of the Chinese healthcare sector with this issue's emphasis on the impacts of ... |
WebEdition/index_1_news.asp?id=6590&sortid=35 | Boehringer Ingelheim's Bet on Chinese CDMO Market Pays Off with Beigene's Mab Approval |
WebEdition/index_1_news.asp?id=6589&sortid=27 | Chinese Scientist Extradited to Stand Trial in the US for Plot to Steal GSK Trade Secrets |
WebEdition/index_1_news.asp?id=6588&sortid=34 | Meeting Clinical Trial Data Requirements In Asian Markets |
WebEdition/index_1_news.asp?id=6587&sortid=25 | U.S.-China Phase I Trade Deal - An Opportunity Window MNCs Must Not Miss |
WebEdition/index_1_news.asp?id=6586&sortid=34 | Recent Announcement for A More Effective Intellectual Property Protection System in China |
WebEdition/index_1_news.asp?id=6585&sortid=35 | Takeda Aspires to Become A Top Ten MNC Pharma Co. in China |
WebEdition/index_1_news.asp?id=6584&sortid=34 | A Few Details on the US-China "Phase One" Trade Deal |
WebEdition/index_1_news.asp?id=6583&sortid=34 | The US-China Trade Deal Phase Two - Digital Trade, IP, Cyber Intrusions, and a Bilateral Investment Treaty |
WebEdition/index_1_news.asp?id=6582&sortid=34 | Here's What's In, What's Out of U.S.-China Trade Deal |
WebEdition/index_1_news.asp?id=6581&sortid=34 | Astrazeneca Rounds Out Stellar China Year - And Beats Roche To The Punch - With Imfinzi Lung Cancer Nod |
WebEdition/index_1_news.asp?id=6580&sortid=34 | China's Cancer Patients Hit by New Law on Experimental Drug Treatments Not Approved by Government |
WebEdition/index_1_news.asp?id=6579&sortid=34 | China Cuts Prices For 70 More Drugs After Talks with Pharmaceutical Firms |
WebEdition/index_1_news.asp?id=6578&sortid=34 | Yaobili Set to Change China's Pharmaceutical Industry with New Model |
WebEdition/index_1_news.asp?id=6577&sortid=34 | Why Chinese Biotech Companies Are Not For Faint-Hearted Investors |
WebEdition/index_1_news.asp?id=6576&sortid=25 | New Round of Negotiation for NRDL Access Begins as Big Pharma Bosses Led Cheers for China at Import Expo |
WebEdition/index_news_news.asp?id=28786&sortid=10 | Recent Executive Moves |
WebEdition/index_news_news.asp?id=28785&sortid=12 | NMPA Clears Phase 3 Trial for SB12, Samsung Bioepis' Bio... |
WebEdition/index_news_news.asp?id=28784&sortid=11 | Eisai Launches Anticancer Agent Halaven in China |
WebEdition/index_news_news.asp?id=28783&sortid=11 | PPD Expanding Capabilities in China |
WebEdition/index_news_news.asp?id=28782&sortid=11 | Shield Therapeutics Licenses China Right of Lead Product to ... |
WebEdition/index_news_news.asp?id=28781&sortid=13 | NMPA Publicizes List of Reference Formulations for Gener... |
WebEdition/index_news_news.asp?id=28780&sortid=13 | NMPA Publicizes List of Reference Formulations for Gener... |
WebEdition/index_news_news.asp?id=28779&sortid=13 | NMPA Deputy Commissioner Meets with PMDA Chief Executive... |
WebEdition/index_news_news.asp?id=28778&sortid=11 | Adagene Snags $69M to Advance Cancer Pipeline |
WebEdition/index_news_news.asp?id=28777&sortid=11 | Targovax and IOVaxis Enters Option Agreement for TG Mutant R... |
WebEdition/index_news_news.asp?id=28776&sortid=13 | CDE Seeks Comments on Guidelines for Generic Drug Resear... |
WebEdition/index_news_news.asp?id=28775&sortid=13 | NMPA Publishes the List of Reference Formulations for Ge... |
WebEdition/index_news_news.asp?id=28774&sortid=12 | HK Researcher Discovers Anticancer NCE Phorbiplatin |
WebEdition/index_news_news.asp?id=28773&sortid=12 | Innovent and Sirnaomics Cooperate to Combine Sintilimab ... |
WebEdition/index_news_news.asp?id=28772&sortid=11 | Sorrento, Mabpharm File NDA for Inflixim... |
WebEdition/index_news_news.asp?id=27219&sortid=27 | Pfizer to Absorb Mylan, Creating Global Generic Powerhou... |
WebEdition/index_news_news.asp?id=26950&sortid=27 | PhRMA Calls for Trade Deals That Force Countries to Pay ... |
WebEdition/index_news_news.asp?id=25636&sortid=27 | IQVIA: Global Pharma to Grow Slower in the Next Five Yea... |
WebEdition/index_news_news.asp?id=25488&sortid=27 | Pfizer and GSK Announce JV to Create a Global Consumer H... |
WebEdition/index_news_news.asp?id=25222&sortid=27 | Top 25 Global Pharmaceutical Companies by Market Cap 201... |
WebEdition/index_news_news.asp?id=28712&sortid=14 | PHIIC: Data Snapshots of Chinese Pharma Market 2013-2019E |
WebEdition/index_news_news.asp?id=28705&sortid=14 | Chinese Cancer Drug Market to Surpass $30+ Billion by 2025 |
WebEdition/index_news_news.asp?id=28697&sortid=14 | NH Reports on Chinese OTC Sleep Aids Market in MAT Q3/2018 |
WebEdition/index_news_news.asp?id=28689&sortid=14 | IQVIA: Chinese Hospital Drug Market Up 9.7% in MAT Q3/2019 |
WebEdition/index_news_news.asp?id=28688&sortid=14 | IQVIA: Chinese Retail Pharmacy Sales Up 1.9% in Q3/2019 |
webedition/index_news.asp?sortid=22 | <img> |
WebEdition/index_news_news.asp?id=28754&sortid=23 | China Jails Three Researchers Involved in Gene-edited Babies... |
WebEdition/index_news_news.asp?id=28745&sortid=23 | China Adopts New Law to Promote Basic Medical and Health Car... |
WebEdition/index_news_news.asp?id=28730&sortid=23 | Chinese Medical Researcher Investigated for Smuggling Vials ... |
WebEdition/index_news_news.asp?id=28707&sortid=23 | Moffitt Cancer Center CEO, Others Resign Over China Ties |
WebEdition/index_news_news.asp?id=28679&sortid=23 | Private Investigator Couple Sue GSK for Misleading Work in C... |
WebEdition/index_news_news.asp?id=28533&sortid=17 | Nikkei: Japan's Generic Drugmakers Have A China Dependen... |
WebEdition/index_news_news.asp?id=28506&sortid=17 | Korea's Growing Reliance on China for API Supply Flagged... |
WebEdition/index_news_news.asp?id=28502&sortid=17 | WuXi STA's Jinshan Facility Passes EMA Inspection |
WebEdition/index_news_news.asp?id=27337&sortid=17 | Novartis Disposes Suzhou Novartis PharmTech in Changshu ... |
WebEdition/index_news_news.asp?id=27336&sortid=17 | FDA Warns Chinese API Producer Yino |
WebEdition/index_news_news.asp?id=28762&sortid=12 | China Approves First Indigenously-developed 13-Valent Pn... |
WebEdition/index_news_news.asp?id=28749&sortid=12 | China's 'Seaweed' Alzheimer's Drug Is Now Available to P... |
WebEdition/index_news_news.asp?id=28759&sortid=15 | NHC Issues the Clinical Pathways for Relevant Disease Gr... |
WebEdition/index_news_news.asp?id=28756&sortid=15 | NHC and SATCM Issues Rules for Internal Price Practices ... |
WebEdition/index_news_news.asp?id=28746&sortid=15 | Document for New Round of National Level Centralized Dru... |
WebEdition/index_news_news.asp?id=28743&sortid=15 | China Launches Mental Health Initiative for Students |
WebEdition/index_news_news.asp?id=28719&sortid=15 | NHC Issues Clinical Application Guidelines for New Antic... |
WebEdition/index_news_news.asp?id=28763&sortid=10 | Recent Executive Moves |
WebEdition/index_news_news.asp?id=28744&sortid=10 | Recent Executive Moves |
WebEdition/index_news_news.asp?id=28695&sortid=10 | Recent Executive Moves |
WebEdition/index_news_news.asp?id=28671&sortid=10 | Recent Executive Moves |
WebEdition/index_news_news.asp?id=28726&sortid=16 | Amid Trade War, China Lowers Import Tariffs on 850 Produ... |
WebEdition/index_news_news.asp?id=28685&sortid=16 | Upcoming Event: International Conference on Biosimilars ... |
WebEdition/index_news_news.asp?id=28615&sortid=16 | Upcoming Event: Biologics Manufacturing Asia 2020 |
WebEdition/index_news_news.asp?id=28580&sortid=16 | Upcoming Event: Asia Wellness Expo 2020 |
WebEdition/index_news_news.asp?id=28579&sortid=16 | Upcoming Event: NanoPharma 2020 |
AboutUs/index_news.asp?lei=WiCON News | <img> |
html/2019-9/972019912311.shtml | WiCON Publishes the China Phar... |
html/2019-2/2262019336501.shtml | WiCON to Hold Pharma China Ann... |
html/2018-12/12132018541241.shtml | WiCON Publishes the China Phar... |
html/2017-5/5192017816291.shtml | WiCON Officially Publishes Chi... |
html/2016-8/8820161239111.shtml | WiCON Officially Publishes Chi... |
myself/index.html | Site map |
myself/in_01.html | Contact Us |
myself/in_02.html | Links |
Domain Name: PHARMACHINAONLINE.COM
Registrar URL: http://www.wildwestdomains.com
Registrant Name: James Shen
Registrant Organization: Wicon International Group LLC
Name Server: NS1.ASPNIX.COM
Name Server: NS2.ASPNIX.COM
For complete domain details go to:
http://who.securepaynet.net/whoischeck.aspx?domain=PHARMACHINAONLINE.COM&prog_id=253410
The data contained in this Registrar's Whois database,
while believed by the registrar to be reliable, is provided "as is"
with no guarantee or warranties regarding its accuracy. This information
is provided for the sole purpose of assisting you in obtaining
information about domain name registration records. Any use of
this data for any other purpose is expressly forbidden without
the prior written permission of this registrar. By submitting an
inquiry, you agree to these terms of usage and limitations of warranty.
In particular, you agree not to use this data to allow, enable, or
otherwise make possible, dissemination or collection of this data, in
part or in its entirety, for any purpose, such as the transmission of
unsolicited advertising and solicitations of any kind, including spam.
You further agree not to use this data to enable high volume, automated
or robotic electronic processes designed to collect or compile this data
for any purpose, including mining this data for your own personal or
commercial purposes.
Please note: the owner of the domain name is specified in the "registrant" section.
In most cases, the Registrar is not the owner of domain names listed in this database.
Китай - 118.102.24.204
China Telecom Beijing
Langfang Development Area Huarui Xintong Network T
HTTP/1.1 200 OK
Cache-Control: private
Content-Type: text/html
Server: Microsoft-IIS/8.5
Set-Cookie: ASPSESSIONIDQCSQBTAQ=GLADGGFDCCHMNJKEPADNHKIA; path=/
X-Powered-By: ASP.NET
Date: Sun, 12 Jan 2020 23:59:23 GMT
Content-Length: 87659
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"